ELUT - Elutia Inc - Ordinary Shares - Class A
IEX Last Trade
4.09
-0.010 -0.244%
Share volume: 42,205
Last Updated: Fri 30 Aug 2024 09:59:55 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$4.10
-0.01
-0.24%
View ratios
| Fiscal Date | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
| Report Date | 2022-08-15 | 2022-11-14 | 2023-03-23 | 2023-05-12 | 2023-08-14 | 2023-11-14 | 2024-03-11 | 2024-05-13 | |
| Assets | |||||||||
| Total Assets | 52.854 M | 61.022 M | 68.841 M | 60.630 M | 52.329 M | 54.580 M | 43.428 M | 35.362 M | |
| Current Assets | 34.684 M | 43.656 M | 50.699 M | 43.466 M | 36.126 M | 39.127 M | 31.253 M | 23.986 M | |
| Inventories | 9.699 M | 10.192 M | 10.052 M | 11.055 M | 9.274 M | 6.503 M | 3.853 M | 3.052 M | |
| Other Current Assets | 1.828 M | 18.204 M | 16.828 M | 13.288 M | 11.239 M | 7.904 M | 4.861 M | 3.977 M | |
| Short Term Investments | 1.828 M | 18.204 M | 16.828 M | 13.288 M | 11.239 M | 7.904 M | 4.861 M | 3.977 M | |
| Total Receivables | 6.646 M | 7.159 M | 6.830 M | 7.334 M | 6.317 M | 2.883 M | 3.263 M | 4.406 M | |
| Current Cash | 16.489 M | 8.101 M | 16.989 M | 11.789 M | 9.296 M | 14.517 M | 19.276 M | 12.551 M | |
| Total Non-current Assets | 18.170 M | 17.366 M | 18.142 M | 17.164 M | 16.203 M | 15.453 M | 12.175 M | 11.376 M | |
| Property Plant Equipment | 1.326 M | 1.359 M | 1.403 M | 1.488 M | 1.467 M | 175.000 K | 172.000 K | 171.000 K | |
| Other Assets | 76.000 K | 89.000 K | 1.670 M | 1.456 M | 1.366 M | 155.000 K | 332.000 K | 383.000 K | |
| Intangible Assets | 16.768 M | 15.918 M | 15.069 M | 14.220 M | 13.370 M | 12.520 M | 11.671 M | 10.822 M | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 52.854 M | 61.022 M | 68.841 M | 60.630 M | 52.329 M | 54.580 M | 43.428 M | 35.362 M | |
| Total liabilities | 54.223 M | 71.703 M | 73.874 M | 72.805 M | 74.457 M | 84.053 M | 82.028 M | 85.661 M | |
| Total current liabilities | 34.749 M | 40.168 M | 42.615 M | 41.424 M | 42.867 M | 44.736 M | 43.037 M | 38.067 M | |
| Accounts Payable | 4.963 M | 5.828 M | 5.480 M | 6.185 M | 5.687 M | 3.669 M | 3.191 M | 5.063 M | |
| Other liabilities | 12.368 M | 11.535 M | 6.043 M | 5.957 M | 5.952 M | 13.454 M | 18.635 M | 27.856 M | |
| Current long term debt | 14.511 M | 0.000 | 682.000 K | 588.000 K | 620.000 K | 399.000 K | 3.596 M | 2.491 M | |
| Long term debt | 7.106 M | 20.000 M | 25.216 M | 25.424 M | 25.638 M | 25.278 M | 20.356 M | 19.738 M | |
| Other liabilities | 12.368 M | 11.535 M | 6.043 M | 5.957 M | 5.952 M | 13.454 M | 18.635 M | 27.856 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | -1.369 M | -10.681 M | -5.033 M | -12.175 M | -22.128 M | -29.473 M | -38.600 M | -50.299 M | |
| Common stock | 13.620 M | 13.661 M | 14.477 M | 16.150 M | 16.224 M | 17.018 M | 23.252 M | 23.912 M | |
| Retained earnings | -122.638 M | -132.548 M | -137.988 M | -145.962 M | -156.583 M | -166.330 M | -175.644 M | -193.638 M |